Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-0.01%
trims when stocks drop
when a holding falls −10%+
Middle response
-10.27%
baseline attrition
Rally response
-2.13%
trims into rallies
when a holding rises +10%+
Top positions · 18
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| ORICORIC Pharmaceuticals, In | $58M | 24.1% | +127.1% | 1.5 yr |
| ALLOAllogene Therapeutics, I | $50M | 20.9% | +67.1% | 1.5 yr |
| ARVNArvinas, Inc. | $35M | 14.6% | +51.0% | 1.5 yr |
| CELCCelcuity Inc. | $31M | 13.1% | +1029.0% | 1.5 yr |
| — | $17M | 7.1% | — | 1.5 yr |
| WVEWave Life Sciences Ltd. | $12M | 5.0% | -10.3% | 1.5 yr |
| PYXSPyxis Oncology, Inc. | $9M | 3.9% | +49.0% | 1.5 yr |
| CRBUCaribou Biosciences, Inc | $8M | 3.5% | +108.1% | 1.5 yr |
| SPROSpero Therapeutics, Inc. | $6M | 2.3% | +225.0% | 1.5 yr |
| — | $4M | 1.8% | — | 1.5 yr |
| CRDFCardiff Oncology, Inc. | $4M | 1.6% | -48.4% | 1.5 yr |
| ZNTLZentalis Pharmaceuticals | $2M | 0.8% | +47.2% | 1.5 yr |
| NXTCNextCure, Inc. | $2M | 0.6% | — | 0.8 yr |
| AGMBAgomAb Therapeutics N.V. | $1M | 0.3% | — | 0.3 yr |
| QTTBQ32 Bio Inc. | $1M | 0.3% | +289.1% | 1.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology91.2%-5.4pp$218M
Unknown8.8%+5.4pp$21M
Country
US85.8%+59.3pp
Unknown8.8%+5.4pp
SG5.0%+2.0pp
BE0.3%
Top 5: 79.8% · Top 10: 96.2% · Top 25: 100.0%
Top buys this quarter · 1
| AGMB AgomAb Therapeutics N.V. Amerinew | +$1M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $239M | 18 | +45.63% | +17.59% | +28.04% | -0.03B |
| 2025-12-31 | $236M | 18 | +21.08% | +17.72% | +3.36% | -0.23B |
| 2025-09-30 | $437M | 21 | +1.90% | +8.12% | -6.23% | -0.15B |
| 2025-06-30 | $575M | 20 | +17.33% | +10.78% | +6.55% | -0.01B |
| 2025-03-31 | $501M | 21 | -4.14% | -4.27% | +0.13% | -1.98B |
| 2024-12-31 | $2.59B | 23 | — | — | — | — |